Hospital consolidation is a common practice, but its benefits can often be accomplished through other mechanisms, said Paul B. Ginsburg, PhD, the Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution and a professor of health policy at the University of Southern California.
Hospital consolidation is a common practice, but its benefits can often be accomplished through other mechanisms, said Paul B. Ginsburg, PhD, the Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution and a professor of health policy at the University of Southern California.
Transcript (slightly modified)
What is important for both payers and consumers to understand when it comes to hospital consolidation?
In a sense, they should be inclined against it and should be demanding of, well, what makes this consolidation different? I’m not saying that all consolidation is bad. Sometimes a hospital may be failing, may not be large enough to be viable, and consolidation is inevitable, either through a merger or through it disappearing from the market.
Certainly, consolidation is one of the tools where providers can better adapt to health IT requirements, reformed provider payments, but very often there are mechanisms short of a merger that can actually accomplish these things. There’s a lot, we call it virtual integration, just contractual relationships between various parties can often accomplish what is claimed as a benefit of consolidation.
How can hospital consolidation be done right?
Well, I think some of the biggest opportunities involve, for example, hospitals not employing physicians, but contracting with physician organizations to partner: partner for a new product, partner in an ACO contract with a health plan. And these potentially can work better, because physician leaders in say, medical groups or independent practice associations may be more successful in fostering changes in behavior by physicians that are needed to do well under reformed payments.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
Proposed SNAP Cuts Could Threaten Prevention for Cognitive Decline, Dementias
July 30th 2025Supplemental Nutrition Assistance Program (SNAP) benefits may slow cognitive decline in older adults, highlighting the importance of food assistance in combating Alzheimer disease and dementia risks.
Read More